INTERNATIONAL PATENT: TRANSGENE FILES APPLICATION FOR "RECOMBINANT POXVIRUS AND METHOD FOR REGULATING THE EXPRESSION OF TOXIC CONDITIONAL GENE PRODUCTS OF SAID RECOMBINANT POXVIRUS IN A PRODUCING CELL"

GENEVA, March 2 -- TRANSGENE (Parc d'innovation Boulevard Gonthier d'Andernach67400 ILLKIRCH GRAFFENSTADEN) filed a patent application (PCT/EP2025/074090) for "RECOMBINANT POXVIRUS AND METHOD FOR REGULATING THE EXPRESSION OF TOXIC CONDITIONAL GENE PRODUCTS OF SAID RECOMBINANT POXVIRUS IN A PRODUCING CELL" on Aug 25, 2025. With publication no. WO/2026/041811, the details related to the patent application was published on Feb 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SILVESTRE, Nathalie (c/o Transgene Parc d'innovation Boulevard Gonthier d'Andernach67400 ILLKIRCH-GRAFFENSTADEN), GEIS...